1,274 research outputs found

    Evaluation Of Culture Media For Counts Of Bifidobacterium Animalis Subsp. Lactis Bb 12 In Yoghurt After Refrigerated Storage

    Get PDF
    The agar RCPB pH5 has been considered a good alternative for counts of Bifidobacterium in yoghurt. However, during the refrigerated storage of yoghurt it is extremely difficult to count this microorganism due to the size of the colonies, which are so small they require the aid of a stereoscope to count them. Another agar, MRS-LP, has been also recommended for counts of Bifidobacterium in the presence of yoghurt bacteria. This study evaluated the supplementation of RCPB pH5 agar with dehydrated liver extract and the salts KH2PO4, K2HPO4, FeSO 47H2O, MnSO4H2O and MgSO 47H2O, aiming at improving the differentiation of Bifidobacterium in yoghurt after refrigerated storage, and also evaluated the selective count of Bifidobacterium in yoghurt using the agar MRS-LP. The agar MRS-LP presented the same cell recovery as non-fortified RCPB pH5 agar, used as a standard medium, thus being considered a good option for counts of Bifidobacterium in yoghurt. The fortified RCPB pH5 also presented the same recovery as the standard RCPB pH5 medium, however, the addition of dehydrated liver extract to the RCPB pH5 agar considerably increased the size of the Bifidobacterium colonies after refrigerated storage, making differentiation of the colonies much easier and reliable when compared to the standard non-fortified RPCP pH5. The addition of the salts (KH2PO4, K2HPO4, FeSO47H2O, MnSO 4H2O and MgSO47H2O) had no influence on the performance of the RCPB pH5 agar.392357361Beehrens, H., An elective and selective isolation medium for Bifidobacterium spp (1990) Lett. Appl. Microbiol, 11 (3), pp. 155-157Bomba, A., Nemcová, R., Mudronová, D., Guba, P., The possibilities of potentiating the efficacy of probiotics (2002) Trends Food Sci. Technol, 13 (4), pp. 121-126Amerian Córdoba Park Hotel (2001) Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, , FAO/WHO, Córdoba, Argentina, 1-4 OctoberGhodussi, H.B., Robinson, R.K., Enumeration of starter cultures in fermented milks (1996) J. Dairy Res, 63 (1), pp. 151-158Lapierre, L., Undeland, P., Cox, L.J., Lithium chloride-sodium propionate agar for the enumeration of Bifidobacteria in fermented dairy products (1992) J. Dairy Sci, 75 (5), pp. 1192-1196Laroia, S., Martin, J.H., Methods for enumerating and propagating Bifidobactéria (1991) Cultured Dairy Prod. J, 26 (2), pp. 32-33Moriya, J., Fachin, L., Gândara, A.L.N., Viotto, W.H., Evaluation of culture media for counts of Bifidobacterium animalis in the presence of yoghurt bacteria (2006) Braz. J. Microbiol, 37, pp. 510-514Onggo, I., Fleet, G.H., Media for the isolation and enumeration of lactic acid bacteria from yoghurts (1993) Aust. J. Dairy Technol, 48 (2), pp. 89-92Payne, J.F., Morris, A.E.J., Beers, P., Evaluation of selective media for the enumeration of Bifidobacterium sp. in milk (1999) J. Appl. Microbiol, 86 (2), pp. 353-358Rybka, S., Kailasapathy, K., Media for the enumeration of yoghurt Bacteria (1996) Int. Dairy J, 6 (8-9), pp. 839-850Vinderola, C.G., Reinheimer, J.A., Culture media for the enumeration of Bifidobacterium bifidum and Lactobacillus acidophilus in the presence of yoghurt bacteria (1999) Int. Dairy J, 9 (8), pp. 497-50

    Advances in Food, Bioproducts and Natural Byproducts for a Sustainable Future: From Conventional to Innovative Processes

    Get PDF
    The world population is expected to reach almost 10,000 million in 2050, which entails the need to focus on sustainability and its three pillars: the economy, the environment, and society. Within this context, it is necessary to use our resources efficiently; for instance, we will need to produce much more food using less land and while polluting less to optimize the production of biomass from diversified resources, along with its subsequent conversion, fractionation, and processing. To achieve this, new approaches and processes, with special emphasis from a biotechnological perspective, may need to be implemented to move towards a circular model that will confer environmental sustainability. Global projections of food losses constitute an abundant pool of complex carbohydrates, proteins, lipids, and functional compounds. Hence, the deployment of food waste streams as raw materials will encompass the formulation of added-value products that will be ideally reintroduced in the food supply chain to close the loop. Therefore, the analysis and optimization of any food and bioproduct process, as well as the development of innovative and emerging food and by-product processing methods, are important as a necessity for the sustainable transition to a bioeconomy era. The valorization, bioprocessing, and biorefining of food-industry-based streams, the role of industrial microorganisms, the isolation of high-added-value compounds, applications of the resulting bio-based chemicals in food manufacturing, novel food formulations, economic policies for food waste management, along with sustainability or techno-economic assessment of processing methods constitute subject areas that need to be addressed. More specifically, bioprocess design to valorize food-industry waste and by-product streams should be initiated by characterizing the composition of the onset raw material with the aim of identifying the target end-products, whereas the generation of multiple high-added-value products is a prerequisite for cost-effective processes to establish economic sustainability. On top of that, the feasibility of innovative processes could be sustained by encompassing food applications, driven by the constantly emerging consumers’ demand for functional foods and beverages with enhanced nutritional value. Equally, a growing awareness for bio-based and natural food components is being developed, thereby imposing challenges on the substitution of chemically derived ingredients with their natural counterparts

    K-Promoted Ni-Based Catalysts for Gas-Phase CO2 Conversion: Catalysts Design and Process Modelling Validation

    Get PDF
    The exponential growth of greenhouse gas emissions and their associated climate change problems have motivated the development of strategies to reduce CO2 levels via CO2 capture and conversion. Reverse water gas shift (RWGS) reaction has been targeted as a promising pathway to convert CO2 into syngas which is the primary reactive in several reactions to obtain high-value chemicals. Among the different catalysts reported for RWGS, the nickel-based catalyst has been proposed as an alternative to the expensive noble metal catalyst. However, Ni-based catalysts tend to be less active in RWGS reaction conditions due to preference to CO2 methanation reaction and to the sintering and coke formation. Due to this, the aim of this work is to study the effect of the potassium (K) in Ni/CeO2 catalyst seeking the optimal catalyst for low-temperature RWGS reaction. We synthesised Ni-based catalyst with different amounts of K:Ni ratio (0.5:10, 1: 10, and 2:10) and fully characterised using different physicochemical techniques where was observed the modification on the surface characteristics as a function of the amount of K. Furthermore, it was observed an improvement in the CO selectivity at a lower temperature as a result of the K-Ni-support interactions but also a decrease on the CO2 conversion. The 1K catalyst presented the best compromise between CO2 conversion, suppression of CO2 methanation and enhancing CO selectivity. Finally, the experimental results were contrasted with the trends obtained from the thermodynamics process modelling observing that the result follows in good agreement with the modelling trends giving evidence of the promising behaviour of the designed catalysts in CO2 highscale units.Ministerio de Ciencia e Innovación PID2019-108502RJ-I00 IJC2019-040560-IMinisterio de Ciencia e Innovación RYC2018-024387-

    Gemcitabine and Irinotecan for Patients with Untreated Extensive Stage Small Cell Lung Cancer: SWOG 0119

    Get PDF
    IntroductionTo evaluate the activity of a nonplatinum-, nonetoposide-containing regimen for patients with extensive stage small cell lung cancer.MethodsPatients with untreated extensive stage small cell lung cancer were treated with gemcitabine 1000 mg/m2 and irinotecan 100 mg/m2 on days 1 and 8 of a 21-day cycle for a maximum of six cycles. Patients with brain metastases were eligible if asymptomatic or controlled after radiation.ResultsEighty-four eligible patients with untreated extensive stage small cell lung cancer with adequate organ function and a performance status of 0–2 were accrued. The median age was 64 years (range, 42–85) and 45 (54%) were women. Six cycles were completed by 28 (33%) patients. Some degree of diarrhea occurred in 57% (grade 3/4, 18%). Other grade 3/4 toxicities were neutropenia (26%), anemia (10%), thrombocytopenia (8%), febrile neutropenia (5%), fatigue (11%), nausea (10%), and vomiting (8%). The response rate was 32% (95% confidence interval: 22%–43%) among the 81 patients with measurable disease. The median survival was 8.5 months (95% confidence interval: 7.0–9.8) with 1- and 2-year survival rates of 26% and 7%, respectively. Salvage therapy data were captured by prospective collection, and only 50% of patients were treated secondarily.ConclusionThe overall response rate with the combination of gemcitabine and irinotecan was disappointing, and the median survival rate was lower than expected. Further development of this combination in small cell lung cancer is not recommended

    Filogenia do gênero Spondias com base em marcadores RAPD resultados preliminares.

    Get PDF
    O trabalho teve como objetivo, estudar as relações de ancestralidade (filogenia) entre as diferentes Spondias visando agrupar as espécies/híbridos com base em marcadores de DNA do tipo RAPD

    A HPLC‐DAD method for identifying and estimating the content of fucoxanthin, β‐carotene and chlorophyll a in brown algal extracts

    Get PDF
    Seaweeds are photosynthetic organisms that have high contents of pigments. The coloration of each alga is defined by the content and combination of pigments synthesized, which varies among species and environmental conditions. The most abundant pigments in algae are chlorophylls and carotenoids, lipophilic molecules that can be used as natural colorants and have high acceptance by consumers. In this work, a simple and short hands-on time HPLC-DAD method for identifying and estimating the pigment content of algal extracts, specifically fucoxanthin, β-carotene and chlorophyll a was carried out. Using this optimized method, a pigment screening was performed on the ethanolic extracts obtained by ultrasound-assisted extraction from nine brown algal from the Atlantic coastline: Ascophyllum nodosum, Bifurcaria bifurcata, Fucus spiralis, Himanthalia elongata, Laminaria saccharina, Laminaria ochroleuca, Pelvetia canaliculata, Sargassum muticum and Undaria pinnatifida. HPLC results permitted to highlight L. saccharina and U. pinnatifida as promising sources of these three target pigments containing a total amount of 10.5 – 11.5 mg per gram of dry weight. Among them, the most abundant one was fucoxanthin, an added-value compound with a high potential to be commercially exploited by different industries, such as the food, cosmetic, and pharmaceutical sectors.The research leading to these results was supported by MICINN sup- porting the Ramón y Cajal grant for M.A. Prieto (RYC-2017-22891), the FPU grant for A. Carreira-Casais (FPU2016/06135); and by Xunta de Galicia for supporting the post-doctoral grant of M. Fraga-Corral (ED481B-2019/096). The research leading to these results was sup- ported by the European Union through the “NextGenerationEU ”pro- gram supporting the “Margarita Salas ”grant awarded to P. Garcia- Perez. Authors are grateful to AlgaMar company ( www.algamar.com ) for the collaboration and algal material provision. This research was funded by the Ibero-American Program on Science and Technology (CYTED —AQUA-CIBUS, P317RT0003), the Bio Based Industries Joint Undertaking (JU) under grant agreement No 888003 UP4HEALTH Project (H2020-BBI-JTI-2019) that supports the work of C. Lourenço- Lopes. The JU receives support from the European Union’s Horizon 2020 research and innovation program and the Bio Based Industries Consor- tium. The project SYSTEMIC Knowledge hub on Nutrition and Food Se- curity, has received funding from national research funding parties in Belgium (FWO), France (INRA), Germany (BLE), Italy (MIPAAF), Latvia (IZM), Norway (RCN), Portugal (FCT), and Spain (AEI) in a joint ac- tion of JPI HDHL, JPI-OCEANS and FACCE-JPI launched in 2019 un- der the ERA-NET ERA-HDHL (n°696295). The authors would like to thank the EU and FCT for funding through the project PTDC/OCE- ETA/30240/2017- SilverBrain - From sea to brain: Green neuropro- tective extracts for nanoencapsulation and functional food production (POCI-01-0145-FEDER-030240).info:eu-repo/semantics/publishedVersio

    The Influence of In Vitro Gastrointestinal Digestion on the Anticancer Activity of Manuka Honey

    Get PDF
    Manuka honey (MH) is a natural food with many beneficial properties to human health, thanks to its high variety of bioactive compounds; however, little is known about its bioaccessibility. The aim of this study was to evaluate and compare the polyphenol compounds, the antioxidant capacity and the anticancer activity of MH subjected to an in vitro gastrointestinal digestion in human HCT-116 colon cancer cells. Raw MH and digested MH (DMH) were assessed for total polyphenols and flavonoids by spectrophotometric and HPLC-ESI-MS/MS analysis, and total antioxidant capacity (TAC) using different methods. Cell viability, intracellular ROS production, apoptosis, cell cycle and colony formation capacity were tested after treatment with MH or DMH. Results showed that total polyphenols, total flavonoids and TAC were significantly (p < 0.05) reduced after in vitro digestion. In addition, MH and DMH at 8, 16 and 24 mg/mL had similar effects in inducing intracellular ROS production and in inhibiting the colon formation ability; MH induced a more marked apoptosis compared to DMH, while cell cycle was blocked in S phase by MH and in Sub G1 phase by DMH. Our results increase knowledge of the effect of gastrointestinal digestion on the biological effect of honey against colorectal cancer

    Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

    Get PDF
    BackgroundThis phase II study (S0027) evaluated the efficacy and tolerability of planned sequential single-agent chemotherapy with vinorelbine followed by docetaxel in patients with advanced non-small cell lung cancer (NSCLC) age 70 and older and/or a performance status (PS) of 2.MethodsPatients with stage IIIB (pleural effusion) or stage IV NSCLC, age 70 and older with a PS of 0-1 or 2, any age, received three cycles of vinorelbine 25 mg/m2 days 1 and 8 every 21 days followed by three cycles of docetaxel 35 mg/m2 days 1, 8, and 15 every 28 days.ResultsA total of 125 patients entered the study; 117 patients were assessable for response, survival, and toxicity. Seventy-five patients were in stratum1 (age 70 and older, PS 0-1) and 42 patients in stratum 2 (PS 2, any age). Objective response was 19% (95% confidence interval [CI]: 11%–30%) and 11% (95% CI: 3%–25%) in strata 1 and 2, respectively. Median survival was 9.1 months (95% CI: 7.1–12.7) and 5.5 months (95% CI: 3.1–6.5) in strata 1 and 2, respectively. Survival at 12 months was 41% and 13% in strata 1 and 2, respectively. Grade 3/4 neutropenia was seen in 32% and 31% of patients in strata 1 and 2, respectively. Three deaths probably related to treatment were noted: one in stratum 1 and two in stratum 2.ConclusionSequential vinorelbine and docetaxel is a well-tolerated and effective regimen in comparison with reports of other treatments tested in patients with advanced NSCLC age 70 and older and/or with a PS of 2
    corecore